Ensign Peak Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.8M | Sell |
1,315,979
-534,060
| -29% | -$23.1M | 0.1% | 184 |
|
|
2025
Q1 | $64M | Sell |
1,850,039
-125,210
| -6% | -$4.33M | 0.12% | 162 |
|
|
2024
Q4 | $54.2M | Buy |
1,975,249
+89,495
| +5% | +$2.46M | 0.1% | 181 |
|
|
2024
Q3 | $48M | Buy |
1,885,754
+239,552
| +15% | +$6.1M | 0.08% | 192 |
|
|
2024
Q2 | $41.7M | Buy |
1,646,202
+506,845
| +44% | +$12.8M | 0.08% | 201 |
|
|
2024
Q1 | $35.2M | Buy |
1,139,357
+394,286
| +53% | +$12.2M | 0.06% | 227 |
|
|
2023
Q4 | $30.1M | Buy |
745,071
+112,361
| +18% | +$4.54M | 0.06% | 254 |
|
|
2023
Q3 | $16.7M | Sell |
632,710
-447,549
| -41% | -$11.8M | 0.04% | 296 |
|
|
2023
Q2 | $18.6M | Hold |
1,080,259
| – | – | 0.04% | 309 |
|
|
2023
Q1 | $17.9M | Buy |
1,080,259
+256,300
| +31% | +$4.25M | 0.04% | 297 |
|
|
2022
Q4 | $6.28M | Buy |
823,959
+262,461
| +47% | +$2M | 0.01% | 507 |
|
|
2022
Q3 | $5.58M | Buy |
561,498
+71,786
| +15% | +$714K | 0.01% | 500 |
|
|
2022
Q2 | $4.45M | Buy |
489,712
+24,629
| +5% | +$224K | 0.01% | 568 |
|
|
2022
Q1 | $4.72M | Sell |
465,083
-7,186
| -2% | -$72.9K | 0.01% | 613 |
|
|
2021
Q4 | $7.88M | Sell |
472,269
-2,551
| -0.5% | -$42.5K | 0.02% | 525 |
|
|
2021
Q3 | $22.3M | Buy |
474,820
+90,682
| +24% | +$4.25M | 0.05% | 300 |
|
|
2021
Q2 | $23.4M | Buy |
384,138
+28,815
| +8% | +$1.76M | 0.05% | 293 |
|
|
2021
Q1 | $21.9M | Buy |
355,323
+175,617
| +98% | +$10.8M | 0.05% | 297 |
|
|
2020
Q4 | $12.8M | Sell |
179,706
-26,945
| -13% | -$1.92M | 0.03% | 383 |
|
|
2020
Q3 | $7.75M | Buy |
206,651
+57,568
| +39% | +$2.16M | 0.02% | 501 |
|
|
2020
Q2 | $4.86M | Buy |
149,083
+6,848
| +5% | +$223K | 0.01% | 614 |
|
|
2020
Q1 | $4.13M | Buy |
142,235
+31,810
| +29% | +$923K | 0.01% | 562 |
|
|
2019
Q4 | $3.87M | Buy |
+110,425
| New | +$3.87M | 0.01% | 724 |
|